Skip to main content
Clinical Trials/DRKS00032985
DRKS00032985
Recruiting
未知

Protection against exercise-induced muscle damage by 8 weeks of Omega-3 supplementation in older adults. - PROTECT

German Institute of Human Nutrition Potsdam-Rehbrücke0 sites44 target enrollmentJanuary 30, 2024
ConditionsInflammation

Overview

Phase
未知
Intervention
Not specified
Conditions
Inflammation
Sponsor
German Institute of Human Nutrition Potsdam-Rehbrücke
Enrollment
44
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 30, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
German Institute of Human Nutrition Potsdam-Rehbrücke

Eligibility Criteria

Inclusion Criteria

  • Age: 65\-85
  • \- BMI between 22\-30 kg/m²

Exclusion Criteria

  • \- Active smokers
  • \- Athletes
  • \- Atrial fibrillation, known/past cardiac arrhythmias or heart attacks
  • \- Arterial hypertension (resting blood pressure \> 140/90 mmHg)
  • \- Taking blood lipid\-lowering drugs (statins), antiarrhythmics (such as flecainide, propafenone, amiodarone, dronedarone) and anticoagulant medications (such as Apixaban, Marcumar)
  • \- Food intolerances/allergies to seafood or algae
  • \- Taking dietary supplements containing polyunsaturated fatty acids, including omega\-3 fatty acids
  • \- Diagnosed with diabetes mellitus
  • \- Presence of malignant neoplasms, HIV
  • \- self\-reported serious diseases of the cardiovascular system such as arteriosclerosis or advanced heart disease (NYHA grade \=2 (New York

Outcomes

Primary Outcomes

Not specified

Similar Trials